PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2024PLoS ONEOpen Access

The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYing KongLHLiang HongXXXiaocheng Xu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kong et al. (2024) studied this question.

synapsesocial.com/papers/68e6d05eb6db64358764e1b4https://doi.org/10.1371/journal.pone.0301931
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2018 · 88,122 citations
  2. 2Cancer Statistics, 20212021 · 17,445 citations
  3. 3A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors2019 · 260 citations
  4. 4Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis2019 · 47 citations